NanoViricides Inc. (NNVC)

[Ubertino]

In re Dr. Corinne Scully and Ebola:

Lectin-Dependent Enhancement of Ebola Virus Infection via Soluble and Transmembrane C-type Lectin Receptors

Matthew Brudner equal contributor,
Marshall Karpel equal contributor,
Calli Lear,
Li Chen,
L. Michael Yantosca,
Corinne Scully,
[Affiliation: Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America]
Ashish Sarraju,
Anna Sokolovska,
M. Reza Zariffard,
Damon P. Eisen,
Bruce A. Mungall,
Darrell N. Kotton,
Amel Omari,
I-Chueh Huang,
Michael Farzan,
Kazue Takahashi,
Lynda Stuart,
Gregory L. Stahl,
Alan B. Ezekowitz,
Gregory T. Spear,
Gene G. Olinger,
Emmett V. Schmidt mail,
Ian C. Michelow mail

Published: April 02, 2013
DOI: 10.1371/journal.pone.0060838

http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060838

Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant

Larry Zeitlina,1, James Pettittb, Corinne Scully b, Natasha Bohorovaa, Do Kima, Michael Paulya, Andrew Hiatta, Long Ngoc, Herta Steinkellnerd, Kevin J. Whaleya, and Gene G. Olingerb
Author Affiliations

aMapp Biopharmaceutical, San Diego, CA 92121;
bDepartment of Virology, US Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702;
cDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215; and
dDepartment of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences, 1190 Vienna, Austria
Edited* by Charles J. Arntzen, Arizona State University, Tempe, AZ, and approved July 28, 2011 (received for review May 25, 2011)

http://www.pnas.org/content/108/51/20690.abstract